Global Gene Knockdown Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Gene Knockdown Revenue
1.4 Market Analysis by Type
1.4.1 Global Gene Knockdown Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 siRNA
1.4.3 shRNA
1.4.4 Other
1.5 Market by Application
1.5.1 Global Gene Knockdown Market Share by Application: 2020 VS 2026
1.5.2 Medical
1.5.3 Bioengineering
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends by Regions
2.1 Gene Knockdown Market Perspective (2015-2026)
2.2 Gene Knockdown Growth Trends by Regions
2.2.1 Gene Knockdown Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Gene Knockdown Historic Market Share by Regions (2015-2020)
2.2.3 Gene Knockdown Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Gene Knockdown Market Growth Strategy
2.3.6 Primary Interviews with Key Gene Knockdown Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Gene Knockdown Players by Market Size
3.1.1 Global Top Gene Knockdown Players by Revenue (2015-2020)
3.1.2 Global Gene Knockdown Revenue Market Share by Players (2015-2020)
3.1.3 Global Gene Knockdown Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Gene Knockdown Market Concentration Ratio
3.2.1 Global Gene Knockdown Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Gene Knockdown Revenue in 2019
3.3 Gene Knockdown Key Players Head office and Area Served
3.4 Key Players Gene Knockdown Product Solution and Service
3.5 Date of Enter into Gene Knockdown Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Gene Knockdown Historic Market Size by Type (2015-2020)
4.2 Global Gene Knockdown Forecasted Market Size by Type (2021-2026)
5 Gene Knockdown Breakdown Data by Application (2015-2026)
5.1 Global Gene Knockdown Market Size by Application (2015-2020)
5.2 Global Gene Knockdown Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Gene Knockdown Market Size (2015-2020)
6.2 Gene Knockdown Key Players in North America (2019-2020)
6.3 North America Gene Knockdown Market Size by Type (2015-2020)
6.4 North America Gene Knockdown Market Size by Application (2015-2020)
7 Europe
7.1 Europe Gene Knockdown Market Size (2015-2020)
7.2 Gene Knockdown Key Players in Europe (2019-2020)
7.3 Europe Gene Knockdown Market Size by Type (2015-2020)
7.4 Europe Gene Knockdown Market Size by Application (2015-2020)
8 China
8.1 China Gene Knockdown Market Size (2015-2020)
8.2 Gene Knockdown Key Players in China (2019-2020)
8.3 China Gene Knockdown Market Size by Type (2015-2020)
8.4 China Gene Knockdown Market Size by Application (2015-2020)
9 Japan
9.1 Japan Gene Knockdown Market Size (2015-2020)
9.2 Gene Knockdown Key Players in Japan (2019-2020)
9.3 Japan Gene Knockdown Market Size by Type (2015-2020)
9.4 Japan Gene Knockdown Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Gene Knockdown Market Size (2015-2020)
10.2 Gene Knockdown Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Gene Knockdown Market Size by Type (2015-2020)
10.4 Southeast Asia Gene Knockdown Market Size by Application (2015-2020)
11 India
11.1 India Gene Knockdown Market Size (2015-2020)
11.2 Gene Knockdown Key Players in India (2019-2020)
11.3 India Gene Knockdown Market Size by Type (2015-2020)
11.4 India Gene Knockdown Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Gene Knockdown Market Size (2015-2020)
12.2 Gene Knockdown Key Players in Central & South America (2019-2020)
12.3 Central & South America Gene Knockdown Market Size by Type (2015-2020)
12.4 Central & South America Gene Knockdown Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Santa Cruz Biotechnology (US)
13.1.1 Santa Cruz Biotechnology (US) Company Details
13.1.2 Santa Cruz Biotechnology (US) Business Overview and Its Total Revenue
13.1.3 Santa Cruz Biotechnology (US) Gene Knockdown Introduction
13.1.4 Santa Cruz Biotechnology (US) Revenue in Gene Knockdown Business (2015-2020))
13.1.5 Santa Cruz Biotechnology (US) Recent Development
13.2 OriGene (US)
13.2.1 OriGene (US) Company Details
13.2.2 OriGene (US) Business Overview and Its Total Revenue
13.2.3 OriGene (US) Gene Knockdown Introduction
13.2.4 OriGene (US) Revenue in Gene Knockdown Business (2015-2020)
13.2.5 OriGene (US) Recent Development
13.3 Sigma-Aldrich (US)
13.3.1 Sigma-Aldrich (US) Company Details
13.3.2 Sigma-Aldrich (US) Business Overview and Its Total Revenue
13.3.3 Sigma-Aldrich (US) Gene Knockdown Introduction
13.3.4 Sigma-Aldrich (US) Revenue in Gene Knockdown Business (2015-2020)
13.3.5 Sigma-Aldrich (US) Recent Development
13.4 Abnova (Taiwan)
13.4.1 Abnova (Taiwan) Company Details
13.4.2 Abnova (Taiwan) Business Overview and Its Total Revenue
13.4.3 Abnova (Taiwan) Gene Knockdown Introduction
13.4.4 Abnova (Taiwan) Revenue in Gene Knockdown Business (2015-2020)
13.4.5 Abnova (Taiwan) Recent Development
13.5 Agilent Technologies (US)
13.5.1 Agilent Technologies (US) Company Details
13.5.2 Agilent Technologies (US) Business Overview and Its Total Revenue
13.5.3 Agilent Technologies (US) Gene Knockdown Introduction
13.5.4 Agilent Technologies (US) Revenue in Gene Knockdown Business (2015-2020)
13.5.5 Agilent Technologies (US) Recent Development
13.6 Bio-Rad (US)
13.6.1 Bio-Rad (US) Company Details
13.6.2 Bio-Rad (US) Business Overview and Its Total Revenue
13.6.3 Bio-Rad (US) Gene Knockdown Introduction
13.6.4 Bio-Rad (US) Revenue in Gene Knockdown Business (2015-2020)
13.6.5 Bio-Rad (US) Recent Development
13.7 Cell Signaling Technology (US)
13.7.1 Cell Signaling Technology (US) Company Details
13.7.2 Cell Signaling Technology (US) Business Overview and Its Total Revenue
13.7.3 Cell Signaling Technology (US) Gene Knockdown Introduction
13.7.4 Cell Signaling Technology (US) Revenue in Gene Knockdown Business (2015-2020)
13.7.5 Cell Signaling Technology (US) Recent Development
13.8 GeneCopoeia (US)
13.8.1 GeneCopoeia (US) Company Details
13.8.2 GeneCopoeia (US) Business Overview and Its Total Revenue
13.8.3 GeneCopoeia (US) Gene Knockdown Introduction
13.8.4 GeneCopoeia (US) Revenue in Gene Knockdown Business (2015-2020)
13.8.5 GeneCopoeia (US) Recent Development
13.9 siTOOLs Biotech (Germany)
13.9.1 siTOOLs Biotech (Germany) Company Details
13.9.2 siTOOLs Biotech (Germany) Business Overview and Its Total Revenue
13.9.3 siTOOLs Biotech (Germany) Gene Knockdown Introduction
13.9.4 siTOOLs Biotech (Germany) Revenue in Gene Knockdown Business (2015-2020)
13.9.5 siTOOLs Biotech (Germany) Recent Development
13.10 Novus Biologicals (US)
13.10.1 Novus Biologicals (US) Company Details
13.10.2 Novus Biologicals (US) Business Overview and Its Total Revenue
13.10.3 Novus Biologicals (US) Gene Knockdown Introduction
13.10.4 Novus Biologicals (US) Revenue in Gene Knockdown Business (2015-2020)
13.10.5 Novus Biologicals (US) Recent Development
13.11 EMD Millipore (US)
10.11.1 EMD Millipore (US) Company Details
10.11.2 EMD Millipore (US) Business Overview and Its Total Revenue
10.11.3 EMD Millipore (US) Gene Knockdown Introduction
10.11.4 EMD Millipore (US) Revenue in Gene Knockdown Business (2015-2020)
10.11.5 EMD Millipore (US) Recent Development
13.12 BioVision (US)
10.12.1 BioVision (US) Company Details
10.12.2 BioVision (US) Business Overview and Its Total Revenue
10.12.3 BioVision (US) Gene Knockdown Introduction
10.12.4 BioVision (US) Revenue in Gene Knockdown Business (2015-2020)
10.12.5 BioVision (US) Recent Development
13.13 Creative Biomart (US)
10.13.1 Creative Biomart (US) Company Details
10.13.2 Creative Biomart (US) Business Overview and Its Total Revenue
10.13.3 Creative Biomart (US) Gene Knockdown Introduction
10.13.4 Creative Biomart (US) Revenue in Gene Knockdown Business (2015-2020)
10.13.5 Creative Biomart (US) Recent Development
13.14 Selleck Chemicals (US)
10.14.1 Selleck Chemicals (US) Company Details
10.14.2 Selleck Chemicals (US) Business Overview and Its Total Revenue
10.14.3 Selleck Chemicals (US) Gene Knockdown Introduction
10.14.4 Selleck Chemicals (US) Revenue in Gene Knockdown Business (2015-2020)
10.14.5 Selleck Chemicals (US) Recent Development
13.15 MyBioSource (US)
10.15.1 MyBioSource (US) Company Details
10.15.2 MyBioSource (US) Business Overview and Its Total Revenue
10.15.3 MyBioSource (US) Gene Knockdown Introduction
10.15.4 MyBioSource (US) Revenue in Gene Knockdown Business (2015-2020)
10.15.5 MyBioSource (US) Recent Development
13.16 Invitrogen (US)
10.16.1 Invitrogen (US) Company Details
10.16.2 Invitrogen (US) Business Overview and Its Total Revenue
10.16.3 Invitrogen (US) Gene Knockdown Introduction
10.16.4 Invitrogen (US) Revenue in Gene Knockdown Business (2015-2020)
10.16.5 Invitrogen (US) Recent Development
13.17 Qiagen (Germany)
10.17.1 Qiagen (Germany) Company Details
10.17.2 Qiagen (Germany) Business Overview and Its Total Revenue
10.17.3 Qiagen (Germany) Gene Knockdown Introduction
10.17.4 Qiagen (Germany) Revenue in Gene Knockdown Business (2015-2020)
10.17.5 Qiagen (Germany) Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of TablesTable 1. Gene Knockdown Key Market Segments
Table 2. Key Players Covered: Ranking by Gene Knockdown Revenue
Table 3. Ranking of Global Top Gene Knockdown Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Gene Knockdown Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of siRNA
Table 6. Key Players of shRNA
Table 7. Key Players of Other
Table 8. Global Gene Knockdown Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Gene Knockdown Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Gene Knockdown Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Gene Knockdown Market Share by Regions (2015-2020)
Table 12. Global Gene Knockdown Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Gene Knockdown Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Gene Knockdown Market Growth Strategy
Table 18. Main Points Interviewed from Key Gene Knockdown Players
Table 19. Global Gene Knockdown Revenue by Players (2015-2020) (Million US$)
Table 20. Global Gene Knockdown Market Share by Players (2015-2020)
Table 21. Global Top Gene Knockdown Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Knockdown as of 2019)
Table 22. Global Gene Knockdown by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Gene Knockdown Product Solution and Service
Table 25. Date of Enter into Gene Knockdown Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Gene Knockdown Market Size by Type (2015-2020) (Million US$)
Table 28. Global Gene Knockdown Market Size Share by Type (2015-2020)
Table 29. Global Gene Knockdown Revenue Market Share by Type (2021-2026)
Table 30. Global Gene Knockdown Market Size Share by Application (2015-2020)
Table 31. Global Gene Knockdown Market Size by Application (2015-2020) (Million US$)
Table 32. Global Gene Knockdown Market Size Share by Application (2021-2026)
Table 33. North America Key Players Gene Knockdown Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Gene Knockdown Market Share (2019-2020)
Table 35. North America Gene Knockdown Market Size by Type (2015-2020) (Million US$)
Table 36. North America Gene Knockdown Market Share by Type (2015-2020)
Table 37. North America Gene Knockdown Market Size by Application (2015-2020) (Million US$)
Table 38. North America Gene Knockdown Market Share by Application (2015-2020)
Table 39. Europe Key Players Gene Knockdown Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Gene Knockdown Market Share (2019-2020)
Table 41. Europe Gene Knockdown Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Gene Knockdown Market Share by Type (2015-2020)
Table 43. Europe Gene Knockdown Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Gene Knockdown Market Share by Application (2015-2020)
Table 45. China Key Players Gene Knockdown Revenue (2019-2020) (Million US$)
Table 46. China Key Players Gene Knockdown Market Share (2019-2020)
Table 47. China Gene Knockdown Market Size by Type (2015-2020) (Million US$)
Table 48. China Gene Knockdown Market Share by Type (2015-2020)
Table 49. China Gene Knockdown Market Size by Application (2015-2020) (Million US$)
Table 50. China Gene Knockdown Market Share by Application (2015-2020)
Table 51. Japan Key Players Gene Knockdown Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Gene Knockdown Market Share (2019-2020)
Table 53. Japan Gene Knockdown Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Gene Knockdown Market Share by Type (2015-2020)
Table 55. Japan Gene Knockdown Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Gene Knockdown Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Gene Knockdown Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Gene Knockdown Market Share (2019-2020)
Table 59. Southeast Asia Gene Knockdown Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Gene Knockdown Market Share by Type (2015-2020)
Table 61. Southeast Asia Gene Knockdown Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Gene Knockdown Market Share by Application (2015-2020)
Table 63. India Key Players Gene Knockdown Revenue (2019-2020) (Million US$)
Table 64. India Key Players Gene Knockdown Market Share (2019-2020)
Table 65. India Gene Knockdown Market Size by Type (2015-2020) (Million US$)
Table 66. India Gene Knockdown Market Share by Type (2015-2020)
Table 67. India Gene Knockdown Market Size by Application (2015-2020) (Million US$)
Table 68. India Gene Knockdown Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Gene Knockdown Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Gene Knockdown Market Share (2019-2020)
Table 71. Central & South America Gene Knockdown Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Gene Knockdown Market Share by Type (2015-2020)
Table 73. Central & South America Gene Knockdown Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Gene Knockdown Market Share by Application (2015-2020)
Table 75. Santa Cruz Biotechnology (US) Company Details
Table 76. Santa Cruz Biotechnology (US) Business Overview
Table 77. Santa Cruz Biotechnology (US) Product
Table 78. Santa Cruz Biotechnology (US) Revenue in Gene Knockdown Business (2015-2020) (Million US$)
Table 79. Santa Cruz Biotechnology (US) Recent Development
Table 80. OriGene (US) Company Details
Table 81. OriGene (US) Business Overview
Table 82. OriGene (US) Product
Table 83. OriGene (US) Revenue in Gene Knockdown Business (2015-2020) (Million US$)
Table 84. OriGene (US) Recent Development
Table 85. Sigma-Aldrich (US) Company Details
Table 86. Sigma-Aldrich (US) Business Overview
Table 87. Sigma-Aldrich (US) Product
Table 88. Sigma-Aldrich (US) Revenue in Gene Knockdown Business (2015-2020) (Million US$)
Table 89. Sigma-Aldrich (US) Recent Development
Table 90. Abnova (Taiwan) Company Details
Table 91. Abnova (Taiwan) Business Overview
Table 92. Abnova (Taiwan) Product
Table 93. Abnova (Taiwan) Revenue in Gene Knockdown Business (2015-2020) (Million US$)
Table 94. Abnova (Taiwan) Recent Development
Table 95. Agilent Technologies (US) Company Details
Table 96. Agilent Technologies (US) Business Overview
Table 97. Agilent Technologies (US) Product
Table 98. Agilent Technologies (US) Revenue in Gene Knockdown Business (2015-2020) (Million US$)
Table 99. Agilent Technologies (US) Recent Development
Table 100. Bio-Rad (US) Company Details
Table 101. Bio-Rad (US) Business Overview
Table 102. Bio-Rad (US) Product
Table 103. Bio-Rad (US) Revenue in Gene Knockdown Business (2015-2020) (Million US$)
Table 104. Bio-Rad (US) Recent Development
Table 105. Cell Signaling Technology (US) Company Details
Table 106. Cell Signaling Technology (US) Business Overview
Table 107. Cell Signaling Technology (US) Product
Table 108. Cell Signaling Technology (US) Revenue in Gene Knockdown Business (2015-2020) (Million US$)
Table 109. Cell Signaling Technology (US) Recent Development
Table 110. GeneCopoeia (US) Business Overview
Table 111. GeneCopoeia (US) Product
Table 112. GeneCopoeia (US) Company Details
Table 113. GeneCopoeia (US) Revenue in Gene Knockdown Business (2015-2020) (Million US$)
Table 114. GeneCopoeia (US) Recent Development
Table 115. siTOOLs Biotech (Germany) Company Details
Table 116. siTOOLs Biotech (Germany) Business Overview
Table 117. siTOOLs Biotech (Germany) Product
Table 118. siTOOLs Biotech (Germany) Revenue in Gene Knockdown Business (2015-2020) (Million US$)
Table 119. siTOOLs Biotech (Germany) Recent Development
Table 120. Novus Biologicals (US) Company Details
Table 121. Novus Biologicals (US) Business Overview
Table 122. Novus Biologicals (US) Product
Table 123. Novus Biologicals (US) Revenue in Gene Knockdown Business (2015-2020) (Million US$)
Table 124. Novus Biologicals (US) Recent Development
Table 125. EMD Millipore (US) Company Details
Table 126. EMD Millipore (US) Business Overview
Table 127. EMD Millipore (US) Product
Table 128. EMD Millipore (US) Revenue in Gene Knockdown Business (2015-2020) (Million US$)
Table 129. EMD Millipore (US) Recent Development
Table 130. BioVision (US) Company Details
Table 131. BioVision (US) Business Overview
Table 132. BioVision (US) Product
Table 133. BioVision (US) Revenue in Gene Knockdown Business (2015-2020) (Million US$)
Table 134. BioVision (US) Recent Development
Table 135. Creative Biomart (US) Company Details
Table 136. Creative Biomart (US) Business Overview
Table 137. Creative Biomart (US) Product
Table 138. Creative Biomart (US) Revenue in Gene Knockdown Business (2015-2020) (Million US$)
Table 139. Creative Biomart (US) Recent Development
Table 140. Selleck Chemicals (US) Company Details
Table 141. Selleck Chemicals (US) Business Overview
Table 142. Selleck Chemicals (US) Product
Table 143. Selleck Chemicals (US) Revenue in Gene Knockdown Business (2015-2020) (Million US$)
Table 144. Selleck Chemicals (US) Recent Development
Table 145. MyBioSource (US) Company Details
Table 146. MyBioSource (US) Business Overview
Table 147. MyBioSource (US) Product
Table 148. MyBioSource (US) Revenue in Gene Knockdown Business (2015-2020) (Million US$)
Table 149. MyBioSource (US) Recent Development
Table 150. Invitrogen (US) Company Details
Table 151. Invitrogen (US) Business Overview
Table 152. Invitrogen (US) Product
Table 153. Invitrogen (US) Revenue in Gene Knockdown Business (2015-2020) (Million US$)
Table 154. Invitrogen (US) Recent Development
Table 155. Qiagen (Germany) Company Details
Table 156. Qiagen (Germany) Business Overview
Table 157. Qiagen (Germany) Product
Table 158. Qiagen (Germany) Revenue in Gene Knockdown Business (2015-2020) (Million US$)
Table 159. Qiagen (Germany) Recent Development
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Gene Knockdown Market Share by Type: 2020 VS 2026
Figure 2. siRNA Features
Figure 3. shRNA Features
Figure 4. Other Features
Figure 5. Global Gene Knockdown Market Share by Application: 2020 VS 2026
Figure 6. Medical Case Studies
Figure 7. Bioengineering Case Studies
Figure 8. Other Case Studies
Figure 9. Gene Knockdown Report Years Considered
Figure 10. Global Gene Knockdown Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Gene Knockdown Market Share by Regions: 2020 VS 2026
Figure 12. Global Gene Knockdown Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Gene Knockdown Market Share by Players in 2019
Figure 15. Global Top Gene Knockdown Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Knockdown as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Gene Knockdown Revenue in 2019
Figure 17. North America Gene Knockdown Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Gene Knockdown Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Gene Knockdown Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Gene Knockdown Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Gene Knockdown Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Gene Knockdown Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Gene Knockdown Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Santa Cruz Biotechnology (US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Santa Cruz Biotechnology (US) Revenue Growth Rate in Gene Knockdown Business (2015-2020)
Figure 26. OriGene (US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. OriGene (US) Revenue Growth Rate in Gene Knockdown Business (2015-2020)
Figure 28. Sigma-Aldrich (US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Sigma-Aldrich (US) Revenue Growth Rate in Gene Knockdown Business (2015-2020)
Figure 30. Abnova (Taiwan) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Abnova (Taiwan) Revenue Growth Rate in Gene Knockdown Business (2015-2020)
Figure 32. Agilent Technologies (US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Agilent Technologies (US) Revenue Growth Rate in Gene Knockdown Business (2015-2020)
Figure 34. Bio-Rad (US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Bio-Rad (US) Revenue Growth Rate in Gene Knockdown Business (2015-2020)
Figure 36. Cell Signaling Technology (US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Cell Signaling Technology (US) Revenue Growth Rate in Gene Knockdown Business (2015-2020)
Figure 38. GeneCopoeia (US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. GeneCopoeia (US) Revenue Growth Rate in Gene Knockdown Business (2015-2020)
Figure 40. siTOOLs Biotech (Germany) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. siTOOLs Biotech (Germany) Revenue Growth Rate in Gene Knockdown Business (2015-2020)
Figure 42. Novus Biologicals (US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Novus Biologicals (US) Revenue Growth Rate in Gene Knockdown Business (2015-2020)
Figure 44. EMD Millipore (US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. EMD Millipore (US) Revenue Growth Rate in Gene Knockdown Business (2015-2020)
Figure 46. BioVision (US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. BioVision (US) Revenue Growth Rate in Gene Knockdown Business (2015-2020)
Figure 48. Creative Biomart (US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Creative Biomart (US) Revenue Growth Rate in Gene Knockdown Business (2015-2020)
Figure 50. Selleck Chemicals (US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Selleck Chemicals (US) Revenue Growth Rate in Gene Knockdown Business (2015-2020)
Figure 52. MyBioSource (US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. MyBioSource (US) Revenue Growth Rate in Gene Knockdown Business (2015-2020)
Figure 54. Invitrogen (US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Invitrogen (US) Revenue Growth Rate in Gene Knockdown Business (2015-2020)
Figure 56. Qiagen (Germany) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Qiagen (Germany) Revenue Growth Rate in Gene Knockdown Business (2015-2020)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation